ECHA management board elects new deputy chairman
Martin Lynch takes the role
Lynch, from Ireland, will hold the role for the next two years. Dr Thomas Jakl, from Austria, is chairman.
You may also like
Manufacturing
Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market
Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Ingredients
Pangea Pharmaceuticals launches FDA-approved amlodipine oral solution Sdamlo
Pangea’s Sdamlo, the first FDA-approved amlodipine powder for oral solution, leverages a patent-pending lyophilisation process to enable precise unit-dose delivery and improved administration for paediatric, geriatric and dysphagic patients
Ingredients
Oncodesign Services extends GIP ARRONAX collaboration to secure astatine-211 supply
The company has extended its collaboration with the French radionuclide specialist to secure access to astatine-211, an alpha-emitting radioisotope of growing interest in targeted radiotherapy but constrained by its seven-hour half-life and limited production capacity
Manufacturing
Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas
Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers